v3.25.1
Segment Reporting - Schedule of Presents Major Accounts of Statements of Operations (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Statements of Operations by Segment [Line Items]      
Revenues $ 15,864,773 $ 19,433,945 $ 14,151,516
Cost of revenues (6,952,560) (10,921,753) (7,794,852)
Selling and marketing expenses (4,010,382) (6,710,757) (2,099,968)
General and administrative expenses (4,989,784) (6,697,309) (6,799,634)
Research and development expenses (252,451) (514,411) (411,524)
Loss from disposal of property and equipment (863) (1,719,442)  
Impairment of goodwill (5,617,865)
Impairment of intangible assets (536,206)
Total operating expenses (9,253,480) (21,795,990) (9,311,126)
Segment operating (loss) income (341,267) (13,283,798) (2,954,462)
Interest income, net 243,008 237,054 142,014
Other income, net 160,015 1,069,745 262,442
Segment net (loss) income (273,413) (11,307,239) (2,822,319)
MDMOOC Services [Member]      
Statements of Operations by Segment [Line Items]      
Revenues 13,712,964 10,406,734 12,935,420
Cost of revenues (5,510,088) (5,162,438) (7,166,871)
Selling and marketing expenses (3,799,558) (5,327,266) (2,091,943)
General and administrative expenses (4,815,112) (6,470,944) (6,649,906)
Research and development expenses (252,451) (514,411) (411,524)
Loss from disposal of property and equipment (863) (1,719,442)  
Impairment of goodwill   (5,617,865)  
Impairment of intangible assets   (536,206)  
Total operating expenses (8,867,984) (20,186,134) (9,153,373)
Segment operating (loss) income (665,108) (14,941,838) (3,384,824)
Interest income, net 242,848 216,528 141,866
Other income, net 148,089 1,069,603 262,131
Segment net (loss) income (622,577) (12,955,659) (3,235,426)
Sales of patented drugs [Member]      
Statements of Operations by Segment [Line Items]      
Revenues 2,151,809 9,027,211 1,216,096
Cost of revenues (1,442,472) (5,759,315) (627,981)
Selling and marketing expenses (210,824) (1,383,491) (8,025)
General and administrative expenses (174,672) (226,365) (149,728)
Research and development expenses
Loss from disposal of property and equipment  
Impairment of goodwill    
Impairment of intangible assets    
Total operating expenses (385,496) (1,609,856) (157,753)
Segment operating (loss) income 323,841 1,658,040 430,362
Interest income, net 160 20,526 148
Other income, net 11,926 142 311
Segment net (loss) income $ 349,164 $ 1,648,420 $ 413,107